Notice – Release of ICH S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance S5(R3): Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 21:53 (TU)
Créé le avril 17, 2026, 21:53 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2020-08-10 00:00:00
open_canada_keywords {"fr": ["avis", "Conseil international pour l'harmonisation", "exigences techniques ICH", "orientation S5(R3)", "détection de la toxicité", "reproduction pour les médicaments", "toxicité pour la fertilité masculine"], "en": ["notice", "International Council for-Harmonisation", "ICH Technical Requirements", "guidance S5(R3)", "detection of toxicity", "reproduction for medicinal-products", "toxicity to male-fertility"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis – Publication de l'ICH S5(R3): Détection de la toxicité sur la reproduction et sur la fertilité des mâles des produits pharmaceutiques destinés aux humains
update_frequency as_needed